Research

The Rivera Mindt Lab aims to advance healthy cognitive aging across populations; accelerate the inclusion of under-studied research populations in aging and Alzheimer’s disease and related dementias (ADRD) research; train the next generation of scientists; and inform public health policy through data-driven  approaches.

CLARiTI Study

(212) 540-8484
claritistudy@mssm.edu

Brain diseases, like Alzheimer's and other dementias, can affect everyone. By joining CLARiTI, you can help us find better ways to prevent and better treat diseases that affect brain health. We cannot do this without you - please consider joining us to make an impact and be a part of groundbreaking brain health discoveries.

BEYONDD Study

(212) 468-2194
beyondd@mssm.edu

Understanding how Alzheimer's disease develops in the brain before symptoms appear is a critical step to discovering solutions that aim to one day prevent the disease. Biomarker Evaluation in Young Onset Dementia from Diverse Populations (BEYONDD) is looking to detect Alzheimer's Disease (AD) early in Diverse Populations (DPs).
Participating in the BEYONDD study will allow you to monitor and learn about your own health and the risks for Alzheimer's disease. Your awareness as a participant can be life-changing, and working closely with world-renowned researchers is incredibly valuable to your health and for creating new tools for early brain disease detection.

SALUD Study

(212) 241-6997
saludstudy@mssm.edu

In this five-year observational study, researchers will investigate differences in brain health outcomes among individuals from Latino and Black communities. Studies show that these populations experience higher rates of dementia, yet the reasons remain unclear. By participating in this study, you can help researchers better understand the factors contributing to these patterns.

ADNI Study

(888) 299-ADNI (2364)

The ADNI study actively supports the investigation and development of treatments that slow or stop the progression of Alzheimer's disease (AD). Researchers at over 60 clinical sites in the USA and Canada collect data to study the progression of AD in the human brain across normal aging, mild cognitive impairment (MCI), and Alzheimer's disease and dementia. Click here to learn more about the history of ADNI and the searchers who lead the study.